169 related articles for article (PubMed ID: 16564729)
1. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
Antoine JM; Verstraete L
Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
[No Abstract] [Full Text] [Related]
2. [Minimal ovarian stimulation: certainly less dangerous and probably as efficient].
Emperaire JC
Gynecol Obstet Fertil; 2006 Apr; 34(4):354-5. PubMed ID: 16574462
[No Abstract] [Full Text] [Related]
3. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
Zarek SM; Muasher SJ
Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
[TBL] [Abstract][Full Text] [Related]
4. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
5. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
7. [Pulsatile gonadotropin releasing hormone treatment following previous ovarian hyperstimulation].
Koloszár S; Bártfai G
Orv Hetil; 1993 Jul; 134(28):1521-3. PubMed ID: 8341530
[TBL] [Abstract][Full Text] [Related]
8. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
9. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
10. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
[No Abstract] [Full Text] [Related]
11. Prevention of ovarian hyperstimulation syndrome.
Wiwanitkit V
Fertil Steril; 2011 Jun; 95(8):e65; author reply e66. PubMed ID: 21530962
[No Abstract] [Full Text] [Related]
12. [Some aspects of ovarian hyperstimulation syndrome].
Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
14. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis.
Crochet JR; Yeh JS; Clowse ME; Copland SD
Fertil Steril; 2011 Apr; 95(5):1786.e13-6. PubMed ID: 21168129
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
16. [Natural cycle in vitro fertilization cycle in poor responders].
Reyftmann L; Déchaud H; Loup V; Anahory T; Brunet-Joyeux C; Lacroix N; Hamamah S; Hédon B
Gynecol Obstet Fertil; 2007 Apr; 35(4):352-8. PubMed ID: 17336129
[TBL] [Abstract][Full Text] [Related]
17. In vitro fertilisation: many unknowns.
Prescrire Int; 2001 Dec; 10(56):187-8. PubMed ID: 11824446
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
Spitzer D; Wogatzky J; Murtinger M; Zech MH; Haidbauer R; Zech NH
Fertil Steril; 2011 Jun; 95(8):2742-4.e1. PubMed ID: 21411081
[TBL] [Abstract][Full Text] [Related]
19. Changing attitudes in ovarian stimulation.
Al-Inany H; Wahba A; Peitsidis P
Womens Health (Lond); 2011 Sep; 7(5):505-7. PubMed ID: 21879817
[No Abstract] [Full Text] [Related]
20. [Alternative approaches to ovarian stimulation].
Alvarez S
Gynecol Obstet Fertil; 2007 Sep; 35(9):885-9. PubMed ID: 17825596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
